Data / Form D filings / Orion Biotechnology Canada Ltd.
Orion Biotechnology Canada Ltd.: Form D filings
Orion Biotechnology Canada Ltd., a biotechnology company in Ottawa, Ontario, Canada (Federal Level), filed 6 Form D notices with the SEC between 2020 and 2025. The latest, on August 26, 2025, reports $6.8 million sold of a $15 million offering to 34 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 343 PRESTON STREET, 11TH FLOOR, Ottawa, Ontario, Canada (Federal Level), K1S1N
- Phone
- (343) 291-1032
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1827388
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 26, 2025 | Amendment | $15,000,000 | $6,809,726 | $8,190,274 | 34 | Jul 8, 2024 | sec.gov |
| Jul 23, 2024 | New notice | $5,000,000 | $743,385 | $4,256,615 | 5 | Jul 8, 2024 | sec.gov |
| Mar 15, 2023 | Amendment | $15,000,000 | $9,889,371 | $5,110,629 | 114 | May 28, 2021 | sec.gov |
| Jun 22, 2021 | Amendment | $15,000,000 | $5,437,297 | $9,562,703 | 142 | May 28, 2021 | sec.gov |
| Jun 15, 2021 | New notice | $15,000,000 | $5,437,297 | $9,562,703 | 142 | May 28, 2021 | sec.gov |
| Oct 9, 2020 | New notice | Indefinite | $605,000 | 11 | Sep 24, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Jussup | Executive Officer | |
| Lonnel Coats | Director | |
| Anatolii Klepatsky | Executive Officer, Director | |
| Jean Forcione | Director | |
| Katie Hewitt | Director | |
| Praveen Tyle | Executive Officer, Director | |
| Bradford Smith | Director | |
| Mark Groper | Director |
Every Form D from the week of Aug 25, 2025 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Orion Biotechnology Canada Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.